About-cancer / lapaʻau / lāʻau / myeloproliferative-neoplasms
Ua ʻae ʻia nā lāʻau no Myeloproliferative Neoplasms
Ua helu ʻia kēia ʻaoʻao i nā lāʻau lapaʻau maʻi ʻaʻai i ʻae ʻia e ka Food and Drug Administration (FDA) no nā neoplasms myeloproliferative Loaʻa i ka papa inoa nā inoa generic a me nā inoa. Kākau ʻia kēia ʻaoʻao i nā hui lāʻau maʻamau i hoʻohana ʻia i nā neoplasms myeloproliferative. Ua ʻae ʻia nā lāʻau āpau e kēlā me kēia hui. Eia nō naʻe, ʻaʻole ʻae ʻia nā hui pū lāʻau ponoʻī iā lākou, akā hoʻohana ākea.
Loulou nā inoa lāʻau i nā hōʻuluʻulu manaʻo ʻike maʻi maʻi ʻo NCI. Loaʻa paha nā lāʻau i hoʻohana ʻia i nā neoplasma myeloproliferative ʻaʻole i helu ʻia ma aneʻi.
Ua ʻae ʻia nā lāʻau no Myeloproliferative Neoplasms
Adriamycin PFS (Doxorubicin Hydrochloride)
Adriamycin RDF (Doxorubicin Hydrochloride)
Trioxide ʻo Arsenic
ʻO Azacitidine
Cerubidine (Daunorubicin Hydrochloride)
ʻO Clafen (Cyclophosphamide)
Cyclophosphamide
ʻO Cytarabine
Cytosar-U (Cytarabine)
Cytoxan (Cyclophosphamide)
Dacogen (Decitabine)
ʻO Dasatinib
Daunorubicin Hydrochloride
Decitabine
Doxorubicin Hydrochloride
ʻO Hydratinib Hydrochloride
Gleevec (Imatinib Mesylate)
Imatinib Mesylate
Inrebic (Fedratinib Hydrochloride)
ʻO Jakafi (Ruxolitinib Phosphate)
Nilotinib
Rubidomycin (Daunorubicin Hydrochloride)
ʻO Ruxolitinib Phosphate
Sprycel (Dasatinib)
ʻO Tarabine PFS (Cytarabine)
Tasigna (Nilotinib)
Trisenox (Arsenic Trioxide)
Vidaza (Azacitidine)
Hoʻohui ʻia nā hui lāʻau i hoʻohana ʻia ma Myeloproliferative Neoplasms
ADE
